CC
LPCN icon

Carlson Capital’s Lipocine LPCN Stock Holding History

Carlson Capital’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,412
Closed -$2.31M – 266
2017
Q4 		$2.31M Buy
39,412
+10,000
+34% +$622K 0.04% 212
2017
Q3 		$1.99M Sell
29,412
-5,882
-17% -$425K 0.03% 206
2017
Q2 		$2.41M Sell
35,294
-4,504
-11% -$294K 0.03% 215
2017
Q1 		$2.64M Buy
39,798
+4,292
+12% +$278K 0.03% 229
2016
Q4 		$2.22M Buy
35,506
+10,800
+44% +$684K 0.03% 257
2016
Q3 		$1.87M Sell
24,706
-5,294
-18% -$328K 0.02% 237
2016
Q2 		$1.55M Buy
30,000
+14,069
+88% +$2.18M 0.02% 266
2016
Q1 		$2.75M Buy
15,931
+2,419
+18% +$413K 0.03% 252
2015
Q4 		$2.97M Buy
+13,512
New +$2.83M 0.03% 258

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Carlson Capital's LPCN Position: Q1 2018 in Review

Carlson Capital sold out of Lipocine (LPCN) in Q1 2018, closing a stake of 39,412 shares — an estimated $2.31M sold.

Carlson Capital first reported a position in LPCN in Q4 2015 and held it in 9 quarters. The position peaked at $2.97M in Q4 2015. 27 funds tracked by Wall St. Rank hold LPCN as of Q1 2018.

  • Carlson Capital reported no remaining Lipocine position as of Q1 2018 after selling out during the quarter.
  • Carlson Capital sold 39,412 Lipocine shares in Q1 2018, an estimated $2.31M.
  • Carlson Capital first reported a position in Lipocine in Q4 2015 and held it in 9 quarters.
  • Carlson Capital's Lipocine position peaked at $2.97M in Q4 2015.
  • 27 funds tracked by Wall St. Rank held Lipocine as of Q1 2018.

Based on Carlson Capital's 13F filing for Q1 2018, filed 15 May 2018.